🧠intro to brain and behavior review
13.3 Schizophrenia and psychotic disorders
Last Updated on August 15, 2024
Schizophrenia is a complex mental disorder with a range of symptoms that can severely impact daily life. It's characterized by positive symptoms like hallucinations, negative symptoms like lack of motivation, and cognitive issues affecting memory and thinking.
The causes of schizophrenia are still not fully understood, but research points to a mix of genetic and environmental factors. Treatment typically involves antipsychotic medications and therapy, aiming to manage symptoms and improve quality of life for those affected.
Schizophrenia Symptoms
Positive, Negative, and Cognitive Symptoms
Top images from around the web for Positive, Negative, and Cognitive Symptoms
Frontiers | Early Intervention and a Direction of Novel Therapeutics for the Improvement of ... View original
Is this image relevant?
Schizophrenia Spectrum and Other Psychotic Disorders | Boundless Psychology View original
Is this image relevant?
DSM 5 – Schizophrenia Spectrum and Bipolar Disorders – Psychology View original
Is this image relevant?
Frontiers | Early Intervention and a Direction of Novel Therapeutics for the Improvement of ... View original
Is this image relevant?
Schizophrenia Spectrum and Other Psychotic Disorders | Boundless Psychology View original
Is this image relevant?
1 of 3
Top images from around the web for Positive, Negative, and Cognitive Symptoms
Frontiers | Early Intervention and a Direction of Novel Therapeutics for the Improvement of ... View original
Is this image relevant?
Schizophrenia Spectrum and Other Psychotic Disorders | Boundless Psychology View original
Is this image relevant?
DSM 5 – Schizophrenia Spectrum and Bipolar Disorders – Psychology View original
Is this image relevant?
Frontiers | Early Intervention and a Direction of Novel Therapeutics for the Improvement of ... View original
Is this image relevant?
Schizophrenia Spectrum and Other Psychotic Disorders | Boundless Psychology View original
Is this image relevant?
1 of 3
- Positive symptoms are additional behaviors not seen in healthy individuals
- Hallucinations (auditory, visual, tactile, or olfactory experiences without external stimuli)
- Delusions (fixed, false beliefs not based on reality)
- Disorganized speech (incoherent or tangential speech)
- Grossly disorganized or catatonic behavior (bizarre, agitated, or immobile behavior)
- Negative symptoms reflect a decrease in or lack of normal behaviors
- Diminished emotional expression (flat affect or reduced facial expressions and gestures)
- Avolition (decreased motivation to initiate or complete goal-directed activities)
- Alogia (diminished speech output or poverty of speech content)
- Anhedonia (decreased ability to experience pleasure from normally enjoyable activities)
- Asociality (lack of interest in social interactions or relationships)
- Cognitive symptoms involve impairments in executive functions
- Problems with working memory (difficulty holding and manipulating information in mind)
- Attention deficits (difficulty focusing on relevant stimuli and filtering out distractions)
- Slowed processing speed (reduced ability to quickly process and respond to information)
- Impaired abstract thinking (difficulty understanding and using abstract concepts)
- Diagnostic criteria require the presence of at least two symptoms (with at least one being a positive symptom) for a significant portion of time during a one-month period
Symptom Impact on Functioning
- Positive, negative, and cognitive symptoms can significantly impair an individual's daily functioning
- Difficulty maintaining employment or academic performance
- Strained interpersonal relationships and social withdrawal
- Impaired self-care and independent living skills
- The severity and combination of symptoms can vary widely among individuals with schizophrenia
- Symptoms typically emerge in late adolescence or early adulthood, with a slightly earlier onset in males compared to females
Schizophrenia Etiology
Neurodevelopmental Hypothesis
- Proposes that schizophrenia results from disruptions in early brain development leading to abnormalities in brain structure and function that manifest as symptoms later in life
- Factors contributing to neurodevelopmental disruptions
- Genetic vulnerabilities (inherited risk factors that interact with environmental factors)
- Prenatal infections (maternal influenza, toxoplasmosis, or rubella during pregnancy)
- Obstetric complications (hypoxia, low birth weight, or prenatal malnutrition)
- Evidence supporting the neurodevelopmental hypothesis
- Structural brain abnormalities (enlarged ventricles, reduced cortical volume) in individuals with schizophrenia
- Cognitive and social impairments often precede the onset of psychotic symptoms
- Increased risk of schizophrenia associated with prenatal and perinatal complications
Dopamine Hypothesis
- Suggests that schizophrenia is associated with an imbalance in dopamine neurotransmission, particularly in the mesolimbic and mesocortical pathways
- Excess dopamine activity in the mesolimbic pathway is thought to contribute to positive symptoms
- Mesolimbic pathway projects from the ventral tegmental area to the nucleus accumbens and limbic regions
- Increased dopamine release in this pathway may lead to aberrant salience attribution and psychotic experiences
- Reduced dopamine activity in the mesocortical pathway may be associated with negative and cognitive symptoms
- Mesocortical pathway projects from the ventral tegmental area to the prefrontal cortex
- Decreased dopamine transmission in this pathway may result in impaired executive functioning and motivation
- Evidence supporting the dopamine hypothesis
- Effectiveness of antipsychotic medications that block dopamine D2 receptors in reducing positive symptoms
- Psychostimulants (amphetamine, cocaine) that increase dopamine release can induce psychotic symptoms in healthy individuals
- Neuroimaging studies showing increased dopamine synthesis and release in the striatum of individuals with schizophrenia
Schizophrenia Subtypes
Paranoid Schizophrenia
- Characterized by prominent delusions and hallucinations with relatively intact cognitive functioning and affect
- Delusions are often persecutory (belief that one is being harassed, followed, or plotted against) or grandiose (belief in having exceptional abilities, wealth, or fame)
- Hallucinations are typically auditory (hearing voices that comment on one's behavior or give commands)
- Paranoid schizophrenia has a later onset and better prognosis compared to other subtypes
Disorganized Schizophrenia
- Involves disorganized speech, behavior, and flat or inappropriate affect with less prominent delusions and hallucinations
- Disorganized speech may include loose associations, tangentiality, or incoherence ("word salad")
- Disorganized behavior may involve childlike silliness, unpredictable agitation, or inappropriate sexual behavior
- Flat affect is characterized by a lack of emotional expressiveness, while inappropriate affect involves emotional responses inconsistent with the situation
Catatonic Schizophrenia
- Marked by unusual motor behaviors, such as excessive and purposeless movement or rigid, fixed postures
- Catatonic excitement involves agitated, repetitive movements or purposeless overactivity
- Catatonic stupor is characterized by immobility, mutism, and posturing (maintaining rigid, awkward positions for extended periods)
- Other catatonic features may include echolalia (repeating others' words) or echopraxia (mimicking others' movements)
Other Schizophrenia Subtypes and Related Disorders
- Undifferentiated schizophrenia is diagnosed when symptoms do not clearly fit into other subtypes or when multiple subtypes are present
- Residual schizophrenia is characterized by a history of at least one episode of schizophrenia but currently with only negative symptoms or attenuated positive symptoms
- Brief psychotic disorder involves the sudden onset of psychotic symptoms lasting less than one month, often in response to a stressful event
- Schizophreniform disorder is characterized by schizophrenia-like symptoms lasting between one and six months
- Schizoaffective disorder involves a combination of schizophrenia symptoms and mood disorder symptoms (depression or mania)
Schizophrenia Treatment
Antipsychotic Medications
- First-line treatment for schizophrenia, primarily targeting dopamine receptors
- Effective in reducing positive symptoms but have limited efficacy for negative and cognitive symptoms
- First-generation (typical) antipsychotics (haloperidol, chlorpromazine)
- Associated with a higher risk of extrapyramidal side effects (tardive dyskinesia, parkinsonism, akathisia)
- Extrapyramidal side effects result from dopamine blockade in the nigrostriatal pathway
- Second-generation (atypical) antipsychotics (risperidone, olanzapine, quetiapine)
- Have a lower risk of extrapyramidal side effects due to their action on both dopamine and serotonin receptors
- May cause metabolic side effects (weight gain, diabetes, dyslipidemia)
- Clozapine, an atypical antipsychotic, is often used for treatment-resistant schizophrenia but requires regular blood monitoring due to the risk of agranulocytosis
Psychosocial Interventions
- Used in conjunction with antipsychotic medications to improve functioning, reduce relapse, and enhance medication adherence
- Cognitive-behavioral therapy (CBT) helps patients identify and challenge distorted thoughts and beliefs, develop coping strategies, and improve problem-solving skills
- Family psychoeducation involves educating family members about schizophrenia, improving communication, and reducing expressed emotion (critical or overprotective attitudes)
- Social skills training focuses on improving patients' ability to interact with others, manage social situations, and develop independent living skills
- Supported employment and education programs help patients achieve vocational and academic goals by providing job coaching, accommodations, and ongoing support
Treatment Challenges and Approaches
- Medication non-adherence is common and can lead to relapse and rehospitalization
- Strategies to improve adherence include long-acting injectable antipsychotics, patient education, and collaborative decision-making
- Negative and cognitive symptoms often persist despite antipsychotic treatment
- Novel pharmacological targets (glutamate, nicotinic receptors) and cognitive remediation therapy are being explored to address these symptoms
- Relapse prevention requires ongoing medication management, psychosocial support, and monitoring for early warning signs of relapse
- Early intervention during the prodromal phase (before the full onset of psychotic symptoms) may delay or prevent the development of schizophrenia
- A comprehensive, individualized approach that combines medication, psychosocial interventions, and support services is essential for optimizing outcomes and quality of life for individuals with schizophrenia
Key Terms to Review (34)
Schizophrenia: Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. It is characterized by symptoms such as delusions, hallucinations, disorganized thinking, and impaired functioning, which can significantly disrupt daily life. Understanding the biological underpinnings of this disorder involves examining aspects like neural migration during brain development, the role of synaptic plasticity in learning and memory, and the distinct features of psychotic disorders.
Schizophreniform disorder: Schizophreniform disorder is a mental health condition characterized by symptoms of schizophrenia, such as hallucinations, delusions, and disorganized speech, lasting for a duration of at least one month but less than six months. This disorder can be seen as a temporary form of schizophrenia and may serve as an early stage or precursor to a more persistent psychotic disorder. Individuals with this condition often experience significant distress or impairment in social or occupational functioning.
Paranoid schizophrenia: Paranoid schizophrenia is a subtype of schizophrenia characterized primarily by delusions and auditory hallucinations that often center around themes of persecution or conspiracy. Individuals with this condition may feel as though they are being watched, conspired against, or threatened, which can lead to heightened anxiety and mistrust of others. Understanding paranoid schizophrenia requires recognizing its distinct symptoms, its impact on thought processes, and how it differentiates from other forms of schizophrenia.
Undifferentiated schizophrenia: Undifferentiated schizophrenia is a subtype of schizophrenia characterized by the presence of various symptoms that do not fit neatly into the other specific subtypes of the disorder. This includes a mix of delusions, hallucinations, disorganized speech, and negative symptoms without a clear dominant symptom pattern. People with this subtype often exhibit significant functional impairment, making it crucial to recognize and understand the broad range of symptoms that can manifest.
Disorganized schizophrenia: Disorganized schizophrenia is a subtype of schizophrenia characterized by disorganized speech, behavior, and thought processes, leading to significant impairment in functioning. Individuals with this condition often exhibit incoherent communication, inappropriate emotional responses, and difficulties in organizing their thoughts, which can result in bizarre or erratic behavior. This subtype highlights the impact of cognitive disruptions on daily life and social interactions.
Catatonic schizophrenia: Catatonic schizophrenia is a subtype of schizophrenia characterized by significant motor disturbances, which can manifest as extreme agitation or marked immobility. This form of schizophrenia often involves unusual postures, lack of response to the environment, and a range of stereotypical movements. The condition showcases the diverse nature of schizophrenia, illustrating how it can affect not only thoughts and perceptions but also physical behavior.
Cognitive symptoms: Cognitive symptoms refer to the mental processes that can be impaired in individuals, particularly in the context of schizophrenia and psychotic disorders. These symptoms affect a person's ability to think clearly, concentrate, and process information, leading to difficulties in memory, attention, and decision-making. Understanding these cognitive symptoms is essential for recognizing the overall impact of psychotic disorders on an individual's daily functioning and quality of life.
Residual schizophrenia: Residual schizophrenia is a subtype of schizophrenia characterized by the absence or diminished presence of prominent psychotic symptoms such as delusions and hallucinations, while still showing some residual signs of the disorder, like negative symptoms or impairment in functioning. Individuals with residual schizophrenia may exhibit social withdrawal, lack of motivation, and cognitive deficits, which are typical of the disorder but less intense than during active phases. This condition emphasizes the chronic aspect of schizophrenia where some symptoms may persist even after acute episodes have subsided.
Brief psychotic disorder: Brief psychotic disorder is a mental health condition characterized by the sudden onset of psychotic symptoms, such as delusions, hallucinations, and disorganized thinking, lasting for at least one day but less than a month. This disorder often occurs in response to a stressful event and can significantly impact an individual's ability to function, although it may resolve on its own or with treatment.
Structural brain abnormalities: Structural brain abnormalities refer to physical changes or alterations in the anatomy of the brain that can affect its function. These abnormalities are often observed through neuroimaging techniques and can be associated with various neurological and psychiatric disorders, including schizophrenia and other psychotic disorders. Understanding these changes is crucial for identifying potential causes and mechanisms underlying these conditions.
Clozapine: Clozapine is an atypical antipsychotic medication primarily used to treat schizophrenia, especially in patients who have not responded to other treatments. It works by affecting various neurotransmitter systems in the brain, particularly dopamine and serotonin receptors, which helps reduce symptoms of psychosis such as hallucinations and delusions. Its unique properties also make it effective in managing treatment-resistant schizophrenia and reducing the risk of suicide in these patients.
First-generation antipsychotics: First-generation antipsychotics, also known as typical antipsychotics, are a class of medications primarily used to treat schizophrenia and other psychotic disorders. These drugs work by blocking dopamine receptors in the brain, which helps to reduce symptoms such as hallucinations and delusions. They are often associated with a range of side effects, which can impact patient adherence to treatment.
Second-generation antipsychotics: Second-generation antipsychotics, also known as atypical antipsychotics, are a class of medications used primarily to treat schizophrenia and other psychotic disorders. These drugs are designed to address both positive symptoms, such as hallucinations and delusions, as well as negative symptoms, like social withdrawal and lack of motivation, making them more versatile than older antipsychotics. They typically have a lower risk of causing movement disorders compared to first-generation antipsychotics, but they may still have side effects such as weight gain and metabolic changes.
Negative Symptoms: Negative symptoms refer to the absence or reduction of normal emotional and behavioral functioning in individuals, particularly those diagnosed with schizophrenia. These symptoms can lead to a diminished ability to engage in everyday activities, experience emotions, or connect socially with others. In the context of schizophrenia and psychotic disorders, negative symptoms significantly impact the quality of life and functioning of affected individuals.
Impaired insight: Impaired insight refers to a reduced ability to recognize and understand one’s own mental health condition, particularly the symptoms and implications of that condition. This phenomenon is commonly observed in individuals with psychotic disorders, especially schizophrenia, where their perception of reality may be distorted, leading to a lack of awareness about their illness and its effects on their behavior and thinking.
Positive Symptoms: Positive symptoms are abnormal behaviors that are added to an individual's normal functioning, often seen in conditions like schizophrenia. These symptoms include hallucinations, delusions, and disorganized thinking, which can significantly impact a person's perception of reality and ability to function in everyday life. Understanding positive symptoms is crucial for diagnosing and treating psychotic disorders, as they indicate the presence of pathological processes in the brain.
Brief Psychiatric Rating Scale: The Brief Psychiatric Rating Scale (BPRS) is a clinical assessment tool used to evaluate psychiatric symptoms and their severity in individuals, particularly in the context of schizophrenia and psychotic disorders. This scale helps clinicians measure changes in symptoms over time, making it valuable for treatment monitoring and research purposes. It covers various domains of mental health, such as mood, perception, and behavior, providing a comprehensive view of a patient's psychiatric condition.
Eugene Bleuler: Eugene Bleuler was a Swiss psychiatrist best known for his contributions to the understanding of schizophrenia, a severe mental disorder. He coined the term 'schizophrenia' in 1908 and introduced concepts such as the splitting of psychic functions, which highlighted the fragmented thinking and emotional responses often seen in individuals with this condition. His work significantly shaped how mental health professionals perceive and diagnose psychotic disorders.
Paranoid delusions: Paranoid delusions are false beliefs that someone is being persecuted, conspired against, or targeted in some way, despite a lack of evidence to support these thoughts. These delusions are often associated with severe mental health disorders, particularly schizophrenia, where individuals may feel threatened by others or believe they are under constant surveillance. Paranoid delusions can significantly impact a person's behavior and interactions, leading to isolation and distress.
Social withdrawal: Social withdrawal refers to a condition where an individual disengages from social interactions and relationships, often resulting in isolation and solitude. This behavior can be a significant symptom of various mental health disorders, including schizophrenia and other psychotic disorders, impacting the individual’s ability to connect with others and participate in everyday life.
Auditory hallucinations: Auditory hallucinations are false perceptions of sound, often experienced as hearing voices that are not present in the environment. These experiences are commonly associated with various psychotic disorders, especially schizophrenia, where they can significantly impact an individual's thoughts, emotions, and behavior. Auditory hallucinations can vary in intensity and may involve commands, conversations, or critical commentary, making them a critical focus in understanding psychotic symptoms.
Dopamine hypothesis: The dopamine hypothesis suggests that an overactivity of dopamine transmission in certain brain regions is a key factor in the development of schizophrenia and other psychotic disorders. This theory connects the symptoms of these disorders, such as hallucinations and delusions, to the dysregulation of dopamine, particularly in areas like the mesolimbic pathway. It also highlights how antipsychotic medications, which primarily target dopamine receptors, can alleviate these symptoms, further supporting this hypothesis.
Emil Kraepelin: Emil Kraepelin was a German psychiatrist who is often regarded as one of the founders of modern psychiatric classification and diagnosis. His work laid the foundation for understanding various mental disorders, particularly schizophrenia and mood disorders, by emphasizing the importance of systematic observation and classification based on clinical symptoms and course of illness.
Antipsychotic medications: Antipsychotic medications are drugs used primarily to manage symptoms of psychosis, which can occur in mental health disorders such as schizophrenia and other psychotic disorders. These medications work by influencing neurotransmitter systems in the brain, particularly those involving dopamine, to help stabilize mood and reduce hallucinations or delusions. By alleviating these symptoms, antipsychotics aim to improve overall functioning and quality of life for individuals experiencing severe mental health issues.
Delusions: Delusions are false beliefs that are strongly held despite contrary evidence, often seen in individuals with certain mental health conditions. They can take various forms, such as paranoid delusions, where a person believes they are being targeted or persecuted, or grandiose delusions, where individuals may think they have exceptional abilities or fame. These distorted perceptions can significantly impact a person's thoughts, behaviors, and overall functioning.
Schizoaffective Disorder: Schizoaffective disorder is a mental health condition that features symptoms of both schizophrenia and mood disorders, such as depression or bipolar disorder. Individuals with this disorder experience psychotic symptoms like hallucinations or delusions, along with significant mood disturbances. This combination of symptoms makes it essential to differentiate schizoaffective disorder from both schizophrenia and mood disorders to ensure proper diagnosis and treatment.
Hallucinations: Hallucinations are sensory experiences that occur without an external stimulus, often perceived as real by the individual. These can affect any of the senses, including sight, hearing, touch, taste, and smell. Hallucinations are particularly significant in understanding schizophrenia and psychotic disorders, as they can profoundly impact a person's perception of reality and contribute to the symptoms associated with these conditions.
Mesocortical pathway: The mesocortical pathway is a neural pathway that connects the ventral tegmental area (VTA) in the midbrain to the prefrontal cortex. This pathway is significant for cognitive functions, emotional regulation, and decision-making processes. It plays a critical role in the brain's reward system and is involved in various psychiatric conditions, highlighting its importance in addiction and psychotic disorders.
Genetic predisposition: Genetic predisposition refers to the increased likelihood of developing certain traits or disorders due to one's genetic makeup. This concept emphasizes how inherited genes can influence an individual's susceptibility to various mental health conditions and neurological disorders, interacting with environmental factors to shape overall health outcomes.
Mesolimbic pathway: The mesolimbic pathway is a neural pathway in the brain that is crucial for processing rewards and reinforcing behaviors associated with pleasure. This pathway runs from the ventral tegmental area (VTA) to the nucleus accumbens and is heavily involved in motivation, emotion, and the experience of pleasure. Its activity is linked to addiction, where substances can hijack this system to produce feelings of euphoria, and also plays a role in certain psychiatric disorders, indicating its importance in both reward systems and psychotic conditions.
Neurotransmitter imbalances: Neurotransmitter imbalances refer to the disruption in the normal levels of neurotransmitters, the chemicals that transmit signals in the brain, leading to various psychological and behavioral issues. These imbalances can result from genetic factors, environmental influences, or a combination of both, affecting mood, cognition, and social interactions. Understanding these imbalances is crucial as they play a significant role in conditions such as autism spectrum disorders and schizophrenia, impacting how individuals process information and respond to their surroundings.
DSM-5 Criteria: The DSM-5 criteria are the standardized guidelines used by mental health professionals to diagnose mental disorders, outlining specific symptoms and their duration that must be present for a diagnosis to be made. This system allows for a consistent approach to identifying and categorizing various mental health conditions, helping practitioners communicate effectively about patients' diagnoses and treatment options.
Diathesis-stress model: The diathesis-stress model is a psychological framework that explains how predispositions (diathesis) and environmental factors (stress) interact to influence the development of mental disorders. This model suggests that individuals may have a genetic or biological vulnerability that, when triggered by stressful life events, can lead to the onset of conditions such as mood disorders and psychotic disorders. Understanding this interaction helps in identifying risk factors and potential preventative measures.
Cognitive Behavioral Therapy: Cognitive Behavioral Therapy (CBT) is a form of psychotherapy that focuses on identifying and changing negative thought patterns and behaviors that contribute to emotional distress. By helping individuals understand the connections between their thoughts, feelings, and actions, CBT aims to promote healthier thinking and improve overall mental health outcomes. This approach is particularly effective in addressing a range of mental health issues, including those related to attention regulation and psychotic experiences.